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injury of the myocardium, which is evidenced by significantly lower Troponine I
indices in Gr.1 patients as well as better indices of left ventricular ejection fraction in
the same group.
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Background: Post-procedural residual ST-segment deviation (STD) has been shown
to be a robust and easily assessed prognostic marker for patients undergoing primary
percutaneous coronary intervention (PCI) for ST-segment elevation myocardial
infarction (STEMI). Recent studies have identified pre-procedural serum biochemical
markers predictive of long-term mortality. We investigated the independent additional
value of post-procedural residual STD after accounting for these novel biomarkers.
Methods: We analyzed 530 STEMI patients who underwent primary PCI at our
institution in 2005 – 2006. Samples for C-reactive protein, Troponin T, creatinin, NT-
pro BNP and glucose were acquired from the arterial sheath prior to diagnostic
angiography. ECGs were recorded in the catheterization laboratory at last contrast
injection of the PCI procedure. STD was defined as the sum of cumulative ST-segment
elevation and depression in all 12 leads and trichotomized as 0-2 mm, 2-4 mm and >4
mm of residual deviation. Mortality was assessed at 3-year follow-up.
Results: All biochemical markers and post-procedural STD were predictive of 3-year
mortality in univariable analysis. In multivariable cox-regression analysis, post-
procedural STD (HR 2.12, 95% CI 1.47 - 3.06; P<0.001), creatinin (HR 1.01, 95% CI
1.00 – 1.02; P=0.012), glucose (HR 1.07, 95% CI 1.02 – 1.12; P=0.006) and NT-pro
BNP (HR 1.00, 95% CI 1.00 – 1.00; P<0.001) were predictive of long-term outcome.
Finally, after adjusting for clinical risk factors, post-procedural STD (HR 1.81, 95%
CI 1.17 – 2.82; P=0.008) and NT-pro BNP (HR 1.00, 95% CI 1.00 – 1.00; P=0.012)
remained independent predictors of death at 3-year follow-up.
Conclusion: After adjustment for clinical risk factors and other admission biochemical
markers, post-procedural STD and NT-pro BNP were independent predictors of 3-year
mortality. These results reaffirm the importance of rapid and complete normalization
of the ECG as a marker of successful myocardial reperfusion.
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Background: We have previously shown that older thrombus is associated with a
significant 2-fold higher long-term mortality in STEMI patients after pPCI.
Methods: STEMI patients who were treated in our center with thrombus aspiration
were included if aspirated thrombus material could histopathologically be classified
according to thrombus age and laboratory measurements of at least one biomarker
(tropT, glucose, NT-proBNP, estimated GFR, and CRP) was available. The additional
prognostic value of thrombus age beyond multiple biomarkers and established clinical
risk factors was evaluated in multivariate Cox models.
Results: Serum biomarker levels were similar between patients with fresh and older
thrombus. 60 patients(7%)died within 1 year. Thrombus age remained strongly
associated with 1-year mortality after multivariable adjustment for multiple biomarkers
and established clinical risk factors (HR 2.81; 95%CI 1.45 to 5.43; p=0.002). Addition
of thrombus age to either a model including established clinical risk factors and
biomarkers or a model including solely biomarkers resulted in significant increases in
the discriminative value, as evidenced by net reclassification improvement (0.42;
p<0.01) and integrated discriminative improvement (0.022; p=0.04).
Conclusion: Thrombus age provides independent complementary information to a
multimarker model including established clinical risk factors and multiple biomarkers
for predicting 1-year mortality in STEMI patients treated with pPCI and thrombus
aspiration.
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Background: Post-infarct ventricular septal rupture (PVSR) is a highly morbid
complication of myocardial infarction (MI). Surgical case series fail to capture the
outcomes across the universe of this entity. We therefore sought to describe our
outcomes of all acute PVSRs, with cases identified independent of intervention or
survival.
Methods: The Cleveland Clinic echocardiography database was searched for all
patients with ventricular septal defect or rupture, 1/1/2000 to 4/15/2011. Patients
referred greater than 30 days from index event were excluded.
Results: We identified 69 acute PVSRs from 2000 to 2011, with median time from
onset of MI symptoms to VSR of 5 days. 45 cases (65%) were managed surgically, 16
(23%) medically, 7 (10%) percutaneously, and 1 (1%) transplanted. Percutaneous cases
had been turned down for surgery and had a mean time from VSR to intervention of
2.3 days. One-year mortalities were determined: overall (68%), surgical (56%), medical
(94%), percutaneous (100%), and transplant (0%). Overall mortality was associated
with higher troponin (p=0.016) and RV dysfunction (p=0.017). 33% of cases were
LAD infarcts, which had higher likelihood of non-surgical care (p=0.0005), and had a
78% mortality rate, compared with 62% for RCA infarcts. Notable variables not
associated with management or outcome included admission blood pressure, heart rate,
creatinine, ejection fraction, shunt fraction, or response to balloon pump. There was a
trend of increased mortality in the second-half of the observation period (59% vs 80%,
p=0.06), along with trends of increased history of smoking, prior bypass surgery, and
elevated creatinine.
Conclusion: Current outcomes with acute PVSR remain dismal. Mortality appears to
be rising over the past decade, which we attribute to a more infirm referral population.
In this tertiary care center, outcomes of inoperable patients with acute PVSRs treated
percutaneously or medically were very poor. Aggressive percutaneous hemodynamic
support and earlier treatment may improve outcomes of these patients.
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